DIFFERENTIAL SENSITIVITY OF ADHERENT CFU-BLAST, CFU-MIX, BFU-E, AND CFU-GM TO MAFOSFAMIDE - IMPLICATIONS FOR ADJUSTED DOSE PURGING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION